Detalhe da pesquisa
1.
Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.
Cancer Immunol Immunother
; 73(2): 21, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279995
2.
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report.
Haematologica
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721751
3.
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks.
Cytotherapy
; 22(9): 511-518, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32631696
4.
Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy.
Transfus Med Hemother
; 44(5): 327-336, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29070978
5.
How can Cytokine-induced killer cells overcome CAR-T cell limits.
Front Immunol
; 14: 1229540, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37675107
6.
Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody.
Front Immunol
; 13: 957874, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36119088
7.
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272306
8.
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells.
Oncoimmunology
; 9(1): 1777046, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923140
9.
Fc Glyco- and Fc Protein-Engineering: Design of Antibody Variants with Improved ADCC and CDC Activity.
Methods Mol Biol
; 1827: 381-397, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30196508
10.
Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells.
Cytokine Growth Factor Rev
; 36: 99-105, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28629761
11.
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1.
Oncoimmunology
; 6(8): e1313371, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28919988
12.
Glucocorticoid receptor signalling activates YAP in breast cancer.
Nat Commun
; 8: 14073, 2017 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28102225
13.
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.
Nat Commun
; 8: 15772, 2017 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28598431
14.
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies.
Oncoimmunology
; 5(8): e1199311, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622068